TrialScientific reports2021

Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.

Fahim Ebrahimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.